Ireland's NCPE rates Novo Nordisk's Wegovy cost effective, opening door to reimbursement
Ireland's drug pricing watchdog found Wegovy gives value for money and recommended the health service consider covering it publicly.
Recap by typeshit. Post by Investseekers on X.